Epitope targeting with self-assembled peptide vaccines

David F. Zeigler(TRIA Bioscience (United States)), Christopher H. Clegg(TRIA Bioscience (United States))

npj Vaccines

July 19, 2019

10.1038/s41541-019-0125-5

Cited by 19

Related Papers

A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines

|PLoS ONE|2010|146

Adjuvant solution for pandemic influenza vaccine production

|Proceedings of the National Academy of Sciences|2012|73

Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice

|Antiviral Research|2016|8